South Africa

November/December 2024: Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
Article and Study Summary: Article Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons Published in: N Engl J Med. Published online November 27, 2024. https://doi.org/10.1056/NEJMoa2411858 Authors: Kelley CF, Acevedo-Quiñones M, Agwu AL, et...High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort
Authors: Brenda Gati Mirembe, Deborah Donnell, Meighan Krows, Zinhle Zwane, Elizabeth Bukusi, Ravindre Panchia, Cheryl Louw, Noluthando Mwelase, Pearl Selepe, Melissa Senne, Logashvari Naidoo, Rachel Chihana, Margaret Kasaro, Harriet Nuwagaba-Biribonwoha, Philip...Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis
Authors: Brenner IR, Flanagan CF, Penazzato M, Webb KA, Horsfall SB, Hyle EP, Abrams E, Bacha J, Neilan AM, Collins IJ, Desmonde S, Crichton S, Davies MA, Freedberg KA, Ciaranello AL. Abstract: Background For children with HIV on antiretroviral therapy (ART),...